External link, please review our disclaimer.

NIDA Funding Strategy for Fiscal Year 2010

Based on the FY 2010 appropriation, the National Institute on Drug Abuse (NIDA) has established the following funding policy for non-ARRA related projects.

NIDA will continue to support the:


The FY 2010 average cost of competing grants is allowed to increase by 2% over FY 2009.

Non-Competing Continuations (Type 5)

  • All non-competing continuations (modular and non-modular) will be funded at 99% of committed levels, including co-funds. This policy does not apply to F's, T's, K's, SBIR/STTR and R13s. Future commitments will be adjusted accordingly.
  • Information regarding the NIH Fiscal Policy for Grant Awards - FY 2010 can be found at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-10-039.html

New and Early Stage Investigators

Ruth L. Kirschstein National Research Service Awards (NRSA)

  • NIDA will support a 1% increase at all stipend levels

Search for Funding

Featured Publication

Mentoring, A Guide for Drug Abuse Researchers publication cover

Mentoring: A Guide for Drug Abuse Researchers

Discusses the importance of quality mentorship in drug abuse research and offers suggestions for creating a successful mentor and mentee relationship.

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. NIH...Turning Discovery Into Health

National Institute on Drug Abuse   |   6001 Executive Boulevard, Room 5213   |   Bethesda, MD 20892-9561

Questions for our staff? E-mail information@nida.nih.gov or call 301-443-1124 (240-221-4007 en español).

Mobile Site